Rockefeller Capital Management L.P. Staar Surgical CO Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$51.25 - $79.34 $75,183 - $116,391	1,467 Added 69.1%	3,590 $229,000
Q4 2022 Mar 06, 2023	BUY	$46.82 - $76.2 $9,598 - $15,621	205 Added 10.69%	2,123 $103,000
Q3 2022 Nov 02, 2022	BUY	$70.55 - $111.58 $128,471 - $203,187	1,821 Added 1877.32%	1,918 $135,000
Q2 2022 Aug 12, 2022	BUY	$50.24 - $80.48 $954 - $1,529	19 Added 24.36%	97 $6,000
Q1 2022 May 13, 2022	BUY	$57.98 - $93.5 $3,072 - $4,955	53 Added 212.0%	78 $6,000
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $880 - $1,277	10 Added 66.67%	25 $2,000
Q3 2021 Nov 12, 2021	SELL	$122.75 - $162.68 $6,260 - $8,296	-51 Reduced 77.27%	15 $1,000
Q2 2021 Aug 10, 2021	BUY	$105.76 - $154.96 $1,057 - $1,549	10 Added 17.86%	66 $10,000
Q1 2021 May 11, 2021	SELL	$78.5 - $126.48 $3,218 - $5,185	-41 Reduced 42.27%	56 $5,000
Q4 2020 Feb 12, 2021	BUY	$55.93 - $82.78 $1,454 - $2,152	26 Added 36.62%	97 $7,000
Q3 2020 Nov 13, 2020	BUY	$45.65 - $61.81 $3,241 - $4,388	71 New	71 $4,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.